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A Fellow’s PerspectiveDeena S. Goldwater, MD, PHD“Why would I need to learn geriatric cardiology?
All of my patients are old.
It’s what I practice every day.”
—Anonymous general cardiologistI s the term geriatric cardiology redundant?Technically, geriatric cardiology refers to cardio-vascular care of patients 65 years of age or older.
The United States Census Bureau predicts that by the
year 2050, almost 81 million Americans will fall into
this demographic. The geriatric population is further
broken down into elderly (between ages 75 and 84
years) and very elderly (85 years of age or older),
with numbers reaching 40 million and 13 million
people, respectively (1). Not surprisingly, a recent
survey found that almost 60% of patients who
visited cardiologists over the last year would be
considered geriatric on the basis of age alone (2).
The inevitable conclusion is that any fellow-
in-training entering the ﬁeld of general cardiology
will, by default, practice a considerable amount of
geriatric cardiology. But, is there reason to believe
that cardiovascular management of these older
adults differs from that of younger cardiovascular
patients? In other words, does geriatric cardiology
have more speciﬁc implications for practice and for
fellows-in-training preparing to enter the general
cardiology clinical arena? A clue comes from the
mission statement of the geriatric cardiology mem-
ber section of the American College of Cardiology
(ACC), which states that the practice of geriatric car-
diology should consider “all matters related to
cardiovascular care-giving in relation to aging” (3).
Due, perhaps, to the hospital-based location of
most training programs, cardiology fellows are
trained to react quickly in urgent situations, usingFrom the Icahn School of Medicine at Mount Sinai, New York, New York.guideline-directed algorithms to address a wide
array of cardiovascular diseases and conditions.
Focused problems provoke immediate reactions:
ST-elevation myocardial infarction ¼ percutaneous
coronary intervention; ventricular ﬁbrillation ¼
deﬁbrillation; and massive pulmonary embolism ¼
thrombolysis. Training in action–reaction medicine
can undoubtedly save lives, and easy-to-follow
algorithms provide helpful guidance, as when
deciding between medical therapy and potentially
complex surgical interventions. After completing
general cardiology fellowship, most graduates are
prepared to safely and effectively manage pa-
tients with a diversity of common cardiovascular
problems.
However, elderly patients present with more than
just cardiovascular diagnoses, which creates com-
plexities that challenge this algorithmic approach to
cardiovascular care. In older adults, multiple medical
problems lead to polypharmacy, and varying levels
of frailty, cognitive and functional impairment, and
inadequate social support complicate treatment
plans that would otherwise be easily instated in
younger patients with fewer comorbidities. As a
result, elderly adults are typically under-represented
in clinical trials as compared with registry pop-
ulations (4). Therefore, recommendations based on
trial results are presented with the caveats and un-
certainties inherent in any subgroup analysis.
Consider this statement from the 2014 ACC/American
Heart Association guidelines on blood cholesterol:
“In select individuals [older than 75 years of age],
additional factors may be considered to inform
treatment decisions [for the primary prevention of
atherosclerotic cardiovascular disease]” (5). Like-
wise, the 2007 ACC/American Heart Association
Focused Guideline Update for Percutaneous Coro-
nary Intervention states, “Complications such as
bleeding and stroke mandate careful consideration of
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1402the beneﬁts and risks of PCI in the elderly” (6). To
interpret vague statements such as these and pro-
vide appropriate care for older patients, cardiologists
must embrace the complexity of disease in this
population. Recommendations require thoughtful
individualization, based not just on a given cardio-
vascular diagnosis, but with respect to each patient’s
aging experience.
To address the needs of this growing population
and ensure that future cardiologists are equipped
to practice cardiology “in relation to aging,”
fundamental elements of geriatric medicine must be
incorporated into the cardiology fellowship core
curriculum. Although various geriatric-speciﬁc con-
cepts are considered when caring for older patients,
3 educational topics are crucial: the comprehensive
geriatric assessment, altered pharmacokinetics in
aging, and the concept of frailty. The geriatric
assessment survey, a cornerstone of the patient-
centered care practiced by geriatricians, is a multi-
dimensional tool that looks beyond aspects of
disease (number of diagnoses, number of medica-
tions) to address physical and mental well-being,
quality of life, social support, and long-term life
expectations. By learning to evaluate patients with
this tool, cardiology fellows will gain a better
understanding of how seemingly small changes in
mental and physical health status impact quality of
life, a perspective of the utmost importance to this
population.
Fellows also must understand the complexities
of medication management in elderly patients.
Polypharmacy, deﬁned as the concurrent use of 5 or
more medications, occurs in up to 40% of older
patients (7). Absorption, bioavailability, and volume
of distribution of pharmacologic agents change
dramatically with age, signiﬁcantly increasing the
risk of drug interactions, particularly in patients
with polypharmacy (7). Consider, then, the clinical
practice guidelines for systolic heart failure, which
recommend at least 4 medications to optimize
quality of life and improve mortality; if a patient
with heart failure also requires treatment for
common comorbidities such as diabetes, hyper-
lipidemia, acid reﬂux, and osteoarthritis, then
prescribed medication numbers may easily rise
into the teens. Importantly, the risk of adverse
drug effects is about 50% in patients on 4 chronic
medications and approaches 100% in those taking
more than 7 (8). Moreover, almost one-half of
hospitalizations related to adverse drug events
are attributable to cardiovascular medications
(particularly diuretics, warfarin, beta-blockers, andangiotensin-converting enzyme inhibitors) (8). The
challenge is to prioritize treatments, minimize
dangerous interactions, and optimize quality of life,
a process that is not yet addressed in current
practice guidelines.
Frailty, a term that embraces the colloquial
“older-than-stated-age,” is a syndrome deﬁned by a
lack of physiological reserve across multiple organ
systems that impairs tolerance for stressors. Char-
acteristics include unintentional weight loss, slow
gait speed, reduced grip strength, and impairment
of activities of daily living. Risk factors for frailty
overlap with those for cardiovascular disease and
include diabetes, hypertension, and hyperlipidemia.
Estimates of the prevalence of frailty in the
elderly population range from 10% to 60% (9). Frail
patients face a greater risk of hospitalization, pro-
cedural complications, and mortality across all
medical and surgical domains, including cardi-
ology. Indeed, the increased morbidity and mortal-
ity risk driven by frailty exceeds that predicted
by conventional risk stratiﬁcation schemes for a
number of cardiovascular diseases, including stable
ischemic heart disease and heart failure, as well as
for those facing cardiac surgical procedures or
percutaneous interventions (9). Cardiology fellows
must, therefore, be trained not only to assess for
frailty in individual patients, but also to recognize
potential complications based on that assessment
and tailor management strategies accordingly.
The prevalence of systolic and diastolic heart
failure, atrial ﬁbrillation, aortic stenosis, and elec-
trical conduction defects increases with age, re-
sulting in a signiﬁcant burden of cardiovascular
disease. To address the needs of a growing geriatric
population, future cardiologists require education
speciﬁcally directed at appropriate evaluation and
risk stratiﬁcation of elderly patients. Incorporating
comprehensive geriatric assessments, aging phar-
macokinetics, and frailty into the core curriculum
will arm fellows with the ability to interpret
guideline phrases such as “in select individuals”
and “careful risk beneﬁt analysis” as they relate
to older patients. Ultimately, fellows will under-
stand that the term geriatric cardiology is not
redundant and will begin their cardiology careers
equipped to practice cardiovascular care in relation
to aging.
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